What question did this study set out to answer?

The aim is to explore the potential of ferrocene-based compounds as effective anticancer agents.

Ferrocene-Based Hybrids as Anticancer Agents: Recent Advances and Structure–Activity Insights

View Full Paper

Ask AI

Bookmark

Authors

Review discusses progress on ferrocene hybrids improving anticancer efficacy and overcoming resistance.

The aim is to explore the potential of ferrocene-based compounds as effective anticancer agents.
Review of recent advances in ferrocene-based hybrid molecules.
Discussion on how electronic effects, linker modifications, and substituent patterns impact biological activity.
Focus on the anticancer properties of ferrocene derivatives and their potential to overcome drug resistance.
Ferrocifen demonstrated strong antiproliferative effects against both hormone-dependent and hormone-independent cancer cell lines.
The ferrocene redox cycle leads to increased generation of reactive oxygen species, inducing apoptosis in cancer cells.
Insights gained support the design of selective, redox-active ferrocene anticancer agents.

Sharma et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark